COURTNEY FIORE: Open Payments
NPI 1568707826 · DANVERS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,447 in 63 payments from 17 companies in 2025. Trend: 2023 $1,683 · 2024 $825 · 2025 $1,447
Food & beverage: $1,351Education: $96
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 9 | $214 |
| GENZYME CORPORATION | 4 | $167 |
| ABBVIE INC. | 12 | $159 |
| Lilly USA, LLC | 11 | $152 |
| UCB, Inc. | 2 | $144 |
| Incyte Corporation | 5 | $104 |
| Regeneron Healthcare Solutions, Inc. | 1 | $96 |
| LNHC, Inc | 3 | $72 |
| Amgen Inc. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
Products named: DUPIXENT, NEMLUVIO, TALTZ, Bimzelx, SKYRIZI, OPZELURA, ZELSUVMI, OTEZLA.
Industry payments across MA — which companies pay providers there.
